| ²é¿´: 661 | »Ø¸´: 2 | |||
ÌïÔ°1983ľ³æ (ÕýʽдÊÖ)
|
[½»Á÷]
´ó¼Ò°ïæ¿´ÄÇ¿´ÕâλÉó¸åÈ˵ÄÒâ¼ûÊÇÐÞ»¹ÊÇ¾Ü ÒÑÓÐ2È˲ÎÓë
|
|
This study explores a strategy ...£¨µÚÒ»¾ä×ܽᣩ While the paper has merits, it falls short of fully supporting its major conclusions. A major technical concern is about the time course of transgene expression and assessment of therapeutic benefits. Day 14 post injection would seem to be too short for onset of gene expression from AAV2, as indicated by the low level of IFN. My doubt is further magnified having reviewed Fig. 2B. This does not appear to be AAV mediated expression of GFP, but background instead. Ͷ¸å½«½ü50Ì죬±à¼¸øÁË´óÐÞ£¬µ«ÊÇ´ÓÕâλÉó¸åÈ˵ÄÒâ¼ûÀ´¿´Ëƺõ¶ÔÎÒµÄÎÄÕ²»ÊǺܸÐð£¬ÊDz»ÊÇÓеãÐü°¡£¿ÐÞ¸åÊDz»ÊÇÒªÌØ±ð×¢Òâ°¡ µÚÒ»´ÎͶÎÄÕ£¬¶àл´ó¼ÒÖ¸µ¼£¡ PS:Á½Î»Éó¸åÈË£¬ÁíÍâһλÌáÁ˼¸¸öÎÊÌ⣬¸öÈ˸оõ¶ÔÎÄÕÂµÄÆÀ¼Û»¹ÊDZȽϿ϶¨µÄ [ Last edited by ÌïÔ°1983 on 2011-2-27 at 21:13 ] |
» ²ÂÄãϲ»¶
²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á
ÒѾÓÐ7È˻ظ´
0703»¯Ñ§336·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
[¸´ÊÔµ÷¼Á]Î÷ÄϿƼ¼´óѧ¹ú·À/²ÄÁϵ¼Ê¦ÍƼö
ÒѾÓÐ6È˻ظ´
»¯Ñ§¹¤³Ì321·ÖÇóµ÷¼Á
ÒѾÓÐ12È˻ظ´
211±¾£¬11408Ò»Ö¾Ô¸ÖпÆÔº277·Ö£¬ÔøÔÚÖпÆÔº×Ô¶¯»¯Ëùʵϰ
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶326Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
¶«ÄÏ´óѧ364Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
¹ú×Ô¿ÆÃæÉÏ»ù½ð×ÖÌå
ÒѾÓÐ7È˻ظ´
ҩѧ383 Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Çë°ïæ¿´¿´Éó¸åÈËдµÄÉó¸åÒâ¼ûÊÇʲôÒâ˼°¡£¿
ÒѾÓÐ8È˻ظ´
Âé·³´ó¼Ò°ïæ¿´Ò»ÏÂÉó¸åÈ˵ĵÚÒ»ÌõÒâ¼ûÔõô»Ø¸´°¡
ÒѾÓÐ5È˻ظ´
Éó¸åÈ˵ÄÒâ¼û²»Ì«¿´µÃ¶®£¬²»ÖªµÀÈçºÎ»Ø´ð£¬Çë´ó¼Ò°ïæ
ÒѾÓÐ3È˻ظ´
±»¾Ü¸åÁ˵ÄÉó¸åÈ˵ÄÒâ¼ûÊDz»ÊÇÐÞ¸Äʱºò²»ÓÃresponse°¡£¿
ÒѾÓÐ27È˻ظ´
ÊDz»ÊÇÿ¸öÉó¸åÈ˶¼»á¸ø³öÒâ¼û£¿ÇëÈÈÐĵĴó¼Ò°ïæ½â»ó
ÒѾÓÐ8È˻ظ´
µÚÒ»´ÎͶÎÄÕ£¬ËäÈ»ÊÇСÐÞ£¬µ«ÊÇÉó¸åÈ˸øµÄÉó¸åÒâ¼û¿´²»Ã÷°×°¡£¬Çë¸÷λ°ï棡£¡
ÒѾÓÐ6È˻ظ´
±à¼Ã»Óиø³öÈκÎÒâ¼û£¬Ö»ÓÐÉó¸åÈ˵ÄÒâ¼û£¬Çë´óÅ£¸ø¿´¿´,´ß»¯Ñ§±¨
ÒѾÓÐ10È˻ظ´
Éó¸åÈ˵ÄÒâ¼û£¬ÇóÖú´ó¼Ò°ïæһϹþ
ÒѾÓÐ12È˻ظ´
ÈçºÎ»Ø¸´Éó¸åÈ˵ÄÒâ¼û
ÒѾÓÐ7È˻ظ´
ÎïÀí»¯Ñ§Ñ§±¨£¬ÒѾ·µ»ØÁ½Î»Éó¸åÈËÒâ¼û£¬Çë´ó¼Ò¿´¿´×îºóÓÐûÓпÉÄܱ»¾Üµô£¿
ÒѾÓÐ4È˻ظ´
Âé·³´ó¼Ò°ï濴ϱ༼°Éó¸åÈ˵ÄÒâ¼û ¹òл
ÒѾÓÐ4È˻ظ´
ÂÛÎı»¾Ü£¬µ«±à¼Ëµ°´Éó¸åÈ˵ÄÒâ¼ûÐ޸ĺóÔÙÖØÐÂÌá½»»¹ÊÇÓпÉÄÜ»á½ÓÊÜ
ÒѾÓÐ25È˻ظ´
Éó¸åÈË˵´óÐÞ£¬µ«ÊÇÂÛÎı»¾Ü£¬¸ø±à¼ÔÙ·¢ÓʼþÉêËßÓÐÓÃÂð 7.19 ¸üÐÂ
ÒѾÓÐ30È˻ظ´
¹ØÓÚÉó¸åÈ˵ÄÒâ¼û£¬Çë´ó¼Ò°ïæ¡£×ż±¡£¡£¡£¡£¡£
ÒѾÓÐ4È˻ظ´
Éó¸åÈ˸øµÄÒâ¼û Óе㿴²»¶®¡£°ï°ïæ лл
ÒѾÓÐ9È˻ظ´
¡¾ÇóÖú¡¿ÇëÇó´ó¼Ò°ïæ¿´Ò»ÏÂÉó¸åÈ˵Ļظ´
ÒѾÓÐ6È˻ظ´
Éó¸åÈ˵ÄÒâ¼ûÊǾܾø£¬Ö÷±àºÍ¸±Ö÷±à¸øÁËÐ޸ĵĻú»á£¬Ôõô°ì£¿£¿
ÒѾÓÐ27È˻ظ´
¼±£¬°ïæ¿´¿´Õâ¸öÉó¸åÈ˵ÄÕæÊµÒâ˼ÊÇʲô
ÒѾÓÐ6È˻ظ´
Á½Éó¸åÈ˸ø´óÐÞºóÖØÉ󣬸±Ö÷±àÈ´¸øÁ˸ö¾Ü¸å½áÂÛ£¬ÎÒ¸ÃÕ¦°ì£¿
ÒѾÓÐ34È˻ظ´
ͶSCI´óÐÞ£¬Éó¸åÈË2¸öͬÒâÒ»¸ö¾Ü¸å
ÒѾÓÐ18È˻ظ´
ÇëÎÊ£ºÐ޸ĸåÈç¹û²»°´ÕÕÉó¸åÈ˵ÄÒâ¼ûÐ޸ģ¬»á±»¾Üµôô
ÒѾÓÐ14È˻ظ´
°ïæ¿´¿´ÈçºÎ»Ø¸´Éó¸åÈËÒâ¼û£¬¼±£¡£¡£¡
ÒѾÓÐ5È˻ظ´

bikebi
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 8 (Ó×¶ùÔ°)
- ½ð±Ò: 4910.7
- É¢½ð: 1011
- ºì»¨: 5
- Ìû×Ó: 975
- ÔÚÏß: 109Сʱ
- ³æºÅ: 625725
- ×¢²á: 2008-10-14
- ÐÔ±ð: GG
- רҵ: Äý¾Û̬ÎïÐÔ II £ºµç×ӽṹ
2Â¥2011-02-27 20:24:54
chuzhufei
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
Öг¡Ä§Êõʦ
- SEPI: 5
- Ó¦Öú: 105 (¸ßÖÐÉú)
- ¹ó±ö: 0.001
- ½ð±Ò: 5829.3
- É¢½ð: 7481
- ºì»¨: 30
- ɳ·¢: 1
- Ìû×Ó: 2608
- ÔÚÏß: 1857.6Сʱ
- ³æºÅ: 706214
- ×¢²á: 2009-02-22
- רҵ: µç·Óëϵͳ
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
| Éó¸åÈË˵ÄãµÄʵÑéÊý¾Ý£¨µ¥Î»¡¢±È½Ï·½Ê½µÈ£© ÓëÄãËùµÃµ½µÄ½áÂÛ²»Ïà·ûºÏ£¬ÄãÓ¦¸ÃºÍËûÈÏÕæ½âÊÍÕâ¸ö£¬°ÑÄãµÄ˼Ïë±í´ïÇå³þ£¬²¢ÔÚÔÎÄÖÐժ¼Ïà¹Ø²ÄÁÏÀ´×ôÖ¤ÄãµÄÂÛÊö |
3Â¥2011-02-27 20:25:04













»Ø¸´´ËÂ¥
50